Sirtex Medical Limited – Product Pipeline Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “Sirtex Medical Limited – Product Pipeline Review – Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
Reasons to buy
Summary
Global Market Direct’s pharmaceuticals report, “Sirtex Medical Limited – Product Pipeline Review – Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Sirtex Medical Limited – Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Sirtex Medical Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Sirtex Medical Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Sirtex Medical Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Sirtex Medical Limited’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Sirtex Medical Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Sirtex Medical Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Sirtex Medical Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Sirtex Medical Limited and identify potential opportunities in those areas.
Sirtex Medical Limited Snapshot
Sirtex Medical Limited Overview
Key Information
Key Facts
Sirtex Medical Limited – Research and Development Overview
Key Therapeutic Areas
Sirtex Medical Limited – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Combination Treatment Modalities
Sirtex Medical Limited – Pipeline Products Glance
Sirtex Medical Limited – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Sirtex Medical Limited – Drug Profiles
FOLFOX6 + Sir-Spheres Microspheres + Avastin
Product Description
Mechanism of Action
R&D Progress
Oxaliplatin + Leucovorin + 5-Fluorouracil
Product Description
Mechanism of Action
R&D Progress
SIR-Spheres microspheres + FOLFOX
Product Description
Mechanism of Action
R&D Progress
Sirtex Medical Limited – Pipeline Analysis
Sirtex Medical Limited – Pipeline Products by Therapeutic Class
Sirtex Medical Limited Pipeline Products By Target
Sirtex Medical Limited – Pipeline Products by Route of Administration
Sirtex Medical Limited – Pipeline Products by Molecule Type
Sirtex Medical Limited – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Aug 19, 2010: Sirtex Medical Reports Phase II Trial Results Of SIR-Spheres In Patients With Colorectal Cancer Liver Metastases Who Have Failed Chemotherapy
Aug 19, 2010: Sirtex Medical Reports Phase II Trial Results Of SIR-Spheres In Patients With Colorectal Cancer Liver Metastases Who Have Failed Chemotherapy
Aug 19, 2010: Sirtex Medical Reports Phase III Trial Data Of 90Y-resin Microspheres For Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy
Aug 19, 2010: Sirtex Medical Reports Phase III Trial Data Of 90Y-resin Microspheres For Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy
Jun 13, 2008: SIR-Spheres Microspheres Featured At The 2008 Society Of Nuclear Medicine Annual Meeting
Jun 13, 2008: SIR-Spheres Microspheres Featured At The 2008 Society Of Nuclear Medicine Annual Meeting
May 19, 2008: Sirtex Sponsors Pilot Study Evaluating SIR-Spheres Microspheres For The Treatment Of Unresectable Hepatocelluar Carcinoma
Aug 09, 2007: Review Examines The Use Of Sirtex's SIR-Spheres Microspheres In Patients With Hepatic Colorectal Cancer Metastases
Aug 09, 2007: Review Examines The Use Of Sirtex's SIR-Spheres Microspheres In Patients With Hepatic Colorectal Cancer Metastases
Financial Deals Landscape
Sirtex Medical Limited, Deals Volume Summary, 2004 to YTD 2010
Sirtex Medical Limited, Deals Summary By Region, 2004 to YTD 2010
Sirtex Medical Limited, Deals Summary, 2004 to YTD 2010
Sirtex Medical Limited Detailed Deal Summary
Sirtex Medical Signs Agreement With Peter MacCallum Cancer Centre
Sirtex Medical Signs Licensing Agreement With Synmosa Biopharma
Sirtex Medical Signs Licensing Marketing Agreement With HOIN MEDIBIZ
Licensing Agreements
Ranbaxy Laboratories Enters Into Licensing Agreement With Sirtex Medical
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
Sirtex Medical Limited – Pipeline by Therapy Area and Indication, 2010
Sirtex Medical Limited – Pipeline by Stage of Development, 2010
Sirtex Medical Limited – Combination Treatment Modalities in Pipeline, 2010
Sirtex Medical Limited – Phase III, 2010
Sirtex Medical Limited - Pipeline By Therapeutic Class, 2010
Sirtex Medical Limited - Pipeline By Target, 2010
Sirtex Medical Limited – Pipeline By Route of Administration, 2010
Sirtex Medical Limited – Pipeline By Molecule Type, 2010
Sirtex Medical Limited, Subsidiaries
Sirtex Medical Limited, Deals Summary, 2004 to YTD 2010
Sirtex Medical Limited, Deals Summary by Region, 2004 to YTD 2010
Sirtex Medical Limited, Deals Summary, 2004 to YTD 2010 33
LIST OF FIGURES
Sirtex Medical Limited – Pipeline by Therapy Area and Indication, 2010
Sirtex Medical Limited – Pipeline by Stage of Development, 2010
Sirtex Medical Limited – Combination Treatment Modalities in Pipeline, 2010
Sirtex Medical Limited – Pipeline By Therapeutic Class, 2010
Sirtex Medical Limited - Pipeline By Target, 2010
Sirtex Medical Limited – Pipeline By Route of Administration, 2010 19
Sirtex Medical Limited Overview
Key Information
Key Facts
Sirtex Medical Limited – Research and Development Overview
Key Therapeutic Areas
Sirtex Medical Limited – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Combination Treatment Modalities
Sirtex Medical Limited – Pipeline Products Glance
Sirtex Medical Limited – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Sirtex Medical Limited – Drug Profiles
FOLFOX6 + Sir-Spheres Microspheres + Avastin
Product Description
Mechanism of Action
R&D Progress
Oxaliplatin + Leucovorin + 5-Fluorouracil
Product Description
Mechanism of Action
R&D Progress
SIR-Spheres microspheres + FOLFOX
Product Description
Mechanism of Action
R&D Progress
Sirtex Medical Limited – Pipeline Analysis
Sirtex Medical Limited – Pipeline Products by Therapeutic Class
Sirtex Medical Limited Pipeline Products By Target
Sirtex Medical Limited – Pipeline Products by Route of Administration
Sirtex Medical Limited – Pipeline Products by Molecule Type
Sirtex Medical Limited – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Aug 19, 2010: Sirtex Medical Reports Phase II Trial Results Of SIR-Spheres In Patients With Colorectal Cancer Liver Metastases Who Have Failed Chemotherapy
Aug 19, 2010: Sirtex Medical Reports Phase II Trial Results Of SIR-Spheres In Patients With Colorectal Cancer Liver Metastases Who Have Failed Chemotherapy
Aug 19, 2010: Sirtex Medical Reports Phase III Trial Data Of 90Y-resin Microspheres For Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy
Aug 19, 2010: Sirtex Medical Reports Phase III Trial Data Of 90Y-resin Microspheres For Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy
Jun 13, 2008: SIR-Spheres Microspheres Featured At The 2008 Society Of Nuclear Medicine Annual Meeting
Jun 13, 2008: SIR-Spheres Microspheres Featured At The 2008 Society Of Nuclear Medicine Annual Meeting
May 19, 2008: Sirtex Sponsors Pilot Study Evaluating SIR-Spheres Microspheres For The Treatment Of Unresectable Hepatocelluar Carcinoma
Aug 09, 2007: Review Examines The Use Of Sirtex's SIR-Spheres Microspheres In Patients With Hepatic Colorectal Cancer Metastases
Aug 09, 2007: Review Examines The Use Of Sirtex's SIR-Spheres Microspheres In Patients With Hepatic Colorectal Cancer Metastases
Financial Deals Landscape
Sirtex Medical Limited, Deals Volume Summary, 2004 to YTD 2010
Sirtex Medical Limited, Deals Summary By Region, 2004 to YTD 2010
Sirtex Medical Limited, Deals Summary, 2004 to YTD 2010
Sirtex Medical Limited Detailed Deal Summary
Sirtex Medical Signs Agreement With Peter MacCallum Cancer Centre
Sirtex Medical Signs Licensing Agreement With Synmosa Biopharma
Sirtex Medical Signs Licensing Marketing Agreement With HOIN MEDIBIZ
Licensing Agreements
Ranbaxy Laboratories Enters Into Licensing Agreement With Sirtex Medical
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
Sirtex Medical Limited – Pipeline by Therapy Area and Indication, 2010
Sirtex Medical Limited – Pipeline by Stage of Development, 2010
Sirtex Medical Limited – Combination Treatment Modalities in Pipeline, 2010
Sirtex Medical Limited – Phase III, 2010
Sirtex Medical Limited - Pipeline By Therapeutic Class, 2010
Sirtex Medical Limited - Pipeline By Target, 2010
Sirtex Medical Limited – Pipeline By Route of Administration, 2010
Sirtex Medical Limited – Pipeline By Molecule Type, 2010
Sirtex Medical Limited, Subsidiaries
Sirtex Medical Limited, Deals Summary, 2004 to YTD 2010
Sirtex Medical Limited, Deals Summary by Region, 2004 to YTD 2010
Sirtex Medical Limited, Deals Summary, 2004 to YTD 2010 33
LIST OF FIGURES
Sirtex Medical Limited – Pipeline by Therapy Area and Indication, 2010
Sirtex Medical Limited – Pipeline by Stage of Development, 2010
Sirtex Medical Limited – Combination Treatment Modalities in Pipeline, 2010
Sirtex Medical Limited – Pipeline By Therapeutic Class, 2010
Sirtex Medical Limited - Pipeline By Target, 2010
Sirtex Medical Limited – Pipeline By Route of Administration, 2010 19
